Company intelligence / Profile preview

Qinchunbao Group

Hangzhou, Zhejiang, China

Ownership: Private
Development stage: Other

Overview

The company is historically significant in Chinese medicine, transitioning from a workshop of Huqing Yutang (est. 1874) to independent factory status in 1972 and then evolving into a core part of Qinchunbao Group, with commercialization of several well-known traditional Chinese medicines

Therapeutic areas: Other
Modalities: Small moleculeHerbal productsBotanical extracts
Industry: Biotech

Partnerships

Joint venture established in 1992 with CP Group (泰国正大集团), forming Chia Tai Qinchunbao Pharmaceutical

Beyond the preview

Go deeper on Qinchunbao Group.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Qinchunbao Group.

Explore the full profile